Nexalin Technology (NXL) News Today $3.16 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Nexalin Technology, Inc.: Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | finanznachrichten.deNexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | markets.businessinsider.comReviewing IMRIS (OTCMKTS:IMRSQ) & Nexalin Technology (NASDAQ:NXL)January 13, 2025 | americanbankingnews.comNexalin Technology Completes Phase 1of its Innovative Virtual ClinicDecember 23, 2024 | globenewswire.comMaxim Group Downgrades Nexalin Technology (NXL)December 6, 2024 | msn.comShort Interest in Nexalin Technology, Inc. (NASDAQ:NXL) Drops By 51.7%Nexalin Technology, Inc. (NASDAQ:NXL - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 622,600 shares, a decrease of 51.7% from the October 31st total of 1,290,000 shares. Approximately 6.3% of the company's shares are sold short. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is currently 0.4 days.November 28, 2024 | marketbeat.comNew Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNovember 26, 2024 | globenewswire.comNexalin Technology releases letter to shareholdersNovember 12, 2024 | markets.businessinsider.comIs Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?November 10, 2024 | finance.yahoo.comNexalin Technology’s Strong Financial Position: No Defaults on Senior SecuritiesNovember 10, 2024 | markets.businessinsider.comNexalin Technology regains compliance with Nasdaq continued listing rulesNovember 2, 2024 | markets.businessinsider.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNovember 2, 2024 | markets.businessinsider.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5thNovember 1, 2024 | globenewswire.comNexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNovember 1, 2024 | globenewswire.comEXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's ...October 29, 2024 | msn.comNexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseOctober 28, 2024 | globenewswire.comNexalin announced planned clinical trial utilizing Gen-3 Halo headsetOctober 23, 2024 | markets.businessinsider.comNexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VAOctober 22, 2024 | globenewswire.comEXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small StudyOctober 18, 2024 | msn.comNew Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's PatientsOctober 17, 2024 | globenewswire.comNexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsOctober 14, 2024 | globenewswire.comMaxim Group Initiates Coverage of Nexalin Technology (NXL) with Buy RecommendationOctober 10, 2024 | msn.comNexalin Technology (NASDAQ:NXL) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comNexalin Technology (NASDAQ:NXL) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comNexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentSeptember 5, 2024 | globenewswire.comNexalin Technology Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 2Q 2023)August 12, 2024 | finance.yahoo.comNexalin Technology announces executive departureAugust 1, 2024 | uk.investing.comNexalin Interview to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TVJuly 26, 2024 | finanznachrichten.deNexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use RecoveryJuly 18, 2024 | globenewswire.comNexalin Technology Announces Closing of $5.2 Million Public OfferingJuly 1, 2024 | globenewswire.comThe 3 Smartest Penny Stocks to Buy With Your Money Right NowJuly 1, 2024 | investorplace.comWhy Is Nexalin Technology (NXL) Stock Down 35% Today?June 28, 2024 | investorplace.comNexalin Technology Announces Pricing of $5.2 Million Public OfferingJune 27, 2024 | globenewswire.comNexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and DementiaJune 20, 2024 | globenewswire.comWhy Is Nexalin Technology (NXL) Stock Down 29% Today?June 14, 2024 | investorplace.comNexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)June 13, 2024 | globenewswire.comNexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thJune 4, 2024 | globenewswire.comFDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceJune 3, 2024 | globenewswire.comNexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research EffortsMay 22, 2024 | globenewswire.comNexalin Technology First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.10 loss in 1Q 2023)May 13, 2024 | finance.yahoo.comNXL Stock Earnings: Nexalin Technology Reported Results for Q1 2024May 13, 2024 | investorplace.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23May 9, 2024 | finance.yahoo.comNexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsApril 25, 2024 | finanznachrichten.deNexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsApril 25, 2024 | globenewswire.comTrading was temporarily halted for "NXL" at 11:04 AM with a stated reason of "LULD pause."April 16, 2024 | marketbeat.comTrading was temporarily halted for "NXL" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 16, 2024 | marketbeat.comTrading was temporarily halted for "NXL" at 10:04 AM with a stated reason of "LULD pause."April 16, 2024 | marketbeat.comNexalin Technology advances in mental health treatmentApril 12, 2024 | investing.comNexalin Technology CEO Provides Letter to ShareholdersApril 10, 2024 | globenewswire.comNexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity(TM), a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceApril 6, 2024 | stockhouse.com Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXL Media Mentions By Week NXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NXL News Sentiment▼0.250.47▲Average Business Services News Sentiment NXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NXL Articles This Week▼41▲NXL Articles Average Week Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TELA Bio News Sensus Healthcare News electroCore News FONAR News Fractyl Health News LENSAR News Milestone Scientific News Monogram Orthopaedics News Edap Tms News Hyperfine News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NXL) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
